Intelligent Bio Solutions Overview
Valuation check: INBS's P/E ratio is -0.18, below the Healthcare sector average of 25.72.
Get informed when a big investor buys or sells
+ Follow-0.18
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Intelligent Bio Solutions (INBS) currently reports a P/E ratio of -0.18. That is below the Healthcare sector average of 25.72. Use the charts on this page to explore Intelligent Bio Solutions's P/E ratio history and peer comparisons.
Intelligent Bio Solutions's P/E ratio of -0.18 is lower than the Healthcare sector average of 25.72. That is roughly 100.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Intelligent Bio Solutions's market price to a fundamental measure such as earnings, sales, or book value. At -0.18, INBS can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -0.18, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.72. From there, open related valuation or income-statement pages for Intelligent Bio Solutions, and consider following INBS for alerts when major investors trade the stock.
Intelligent Bio Solutions is classified in the Healthcare sector. On P/E ratio, it currently shows -0.18 versus a sector average near 25.72. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INBS with unrelated industries.
